Dec 152015
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– UK, Oxford – Oxford BioMedica plc (LSE: OXB), a leading gene and cell therapy group, is pleased to announce that Dr. Lorenzo Tallarigo will be appointed as Non-Executive Chairman of the Group on 1 February 2016.

From 2008 to 2014 Dr.Tallarigo was a member of the Board, and Chairman from 2011, of Intercept Pharmaceuticals (Nasdaq:ICPT).… => more

Oxford Biomedica announces Dr Lorenzo Tallarigo to its Board as upcoming Non-Executive Chairman

From:: Oxford Biomedica announces Dr Lorenzo Tallarigo to its Board as upcoming Non-Executive Chairman

 Posted by at 9:36 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: